FDA — authorised 14 November 2013
- Marketing authorisation holder: MEDICIS
- Status: approved
🇺🇸 Luzu in United States
FDA authorised Luzu on 14 November 2013
Marketing authorisations
FDA — authorised 14 November 2013
- Application: NDA204153
- Marketing authorisation holder: BAUSCH
- Local brand name: LUZU
- Indication: CREAM — TOPICAL
- Status: approved
Luzu in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in United States
Frequently asked questions
Is Luzu approved in United States?
Yes. FDA authorised it on 14 November 2013; FDA authorised it on 14 November 2013.
Who is the marketing authorisation holder for Luzu in United States?
MEDICIS holds the US marketing authorisation.